Personalizing
Cancer Treatment for Everyone

Considerations and Advancements of Precision Medicine in GI Cancers

January 12, 2018

by Arturo Loaiza-Bonilla, MD, MSEd

This activity is designed to inform physicians about the current availability and use of targeted therapies and precision medicine in gastric (GC) and other gastrointestinal (GI) cancers. 

This activity is directed toward medical oncologists, primary care physicians, nurses, and nurse practitioners who treat and/or manage patients with GC or other GI cancers. Surgical oncologists, radiation oncologists, pathologists, internists, fellows, physician assistants, and other healthcare providers are also invited to participate. 

PDF Article for Activity 

After completing this CME/CE activity, participants should be better prepared to:

  • Describe the biomarker-based rationale behind GI cancer classifications
  • Explain the development history leading to the approval of targeted therapies in GC and other GI cancers
  • Discuss emerging targeted strategies and new indications for precision medicine in GI cancers 

Read More

 

 

 

Stay in Touch with Us
To speak with a dedicated cancer care specialist, contact us:
PLEASE FILL OUT FORM BELOW

By clicking Submit, you agree to our Terms And Conditions and have read and acknowledge our Privacy Statement.

Top